STM Journals Peer-reviewed research from Consortium e-Learning Network

Research and Reviews : A Journal of Medical Science and Technology Original Research

Weight Loss Surgery Induced Telogen Effluvium (We Loss SITE) Management – Our Experiences

  1. Jacob Antony Chakiath Department of Plastic Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Yanam
  2. Ravi Kumar Chittoria Department of Plastic Surgery, Jawaharlal, Institute of Postgraduate Medical Education and Research, Yanam

Abstract

Telogen effluvium, a condition of non-inflammatory, no-scarring, diffuse hair loss after weight loss surgery. A through history taking and videodermatoscopy is an effective tool for evaluation of a patient with weight loss surgery-induced teleogen effluvium (We Loss SITE). Cyclical nutritional therapy, low level laser therapy, autologous platelet rich plasma are effective treatments for telogen effluvium. This case report shares our experience in the management of a patient with weight loss surgery-induced telogen effluvium. An OPD visit was made by a 23-year-old male patient from Calicut, Kerala, who works as a driver and has had hair loss for two years following bariatric surgery. Since childhood, the patient has been obese. When she became pregnant, his mother had uncontrolled diabetes. At nine months old, she had a caesarean section because of macrosomia. When the patient was delivered, their weight was 6 kg. With age, he began to put on weight gradually. It might be challenging to differentiate between female pattern hair loss and telogen effluvium, a non-inflammatory, widespread hair loss disorder. The entire scalp usually experiences hair loss, albeit on occasion the temporal regions show the most signs of it. The hair-pull test is positive, with increased shedding of telogen hairs when telogen effluvium is active. In our patient with weight loss surgery induced telogen effluvium, videodermatoscopy was helpful for diagnosis. Autologous platelet-rich plasma therapy, low-intensity laser therapy, and cyclical nutritional therapy all contributed to the restoration of better hair.

Keywords

References (19)

  1. Thiedke CC. Alopecia in women. Am Fam Physician. 2003;67(5):1007–1014.
  2. Mounsey AL, Reed SW. Diagnosing and treating hair loss. Am Fam Physician. 2009;80(4):356–362.
  3. Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9(9):WE01–WE03. doi:7860/JCDR/2015/15219.6492.
  4. Rebora A. Telogen effluvium: a comprehensive review. Clinical, Cosmetic and Investigational Dermatology. 2019;Volume12:583-590. doi:10.2147/ccid.s200471
  5. Ross EK, Vincenzi C, Tosti A. Videodermoscopy in the evaluation of hair and scalp disorders. Journal of the American Academy of Dermatology. 2006;55(5):799-806. doi:10.1016/j.jaad.2006.04.058
  6. Bernstein RM, Rassman WR. Densitometry and Video-microscopy. International Society of Hair Restoration Surgery. 2007;17(2):41-51. doi:10.33589/17.2.0041
  7. Irwig MS. Persistent Sexual Side Effects of Finasteride: Could They be Permanent? The Journal of Sexual Medicine. 2012;9(11):2927-2932. doi:10.1111/j.1743-6109.2012.02846.x
  8. Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse Side Effects of 5α-Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients. The Journal of Sexual Medicine. 2011;8(3):872-884. doi:10.1111/j.1743-6109.2010.02157.x
  9. Rajput R. The Concept of Cyclical Nutritional Therapy for Hair Growth which can be Applied for Wellness. Journal of Nutrition & Food Sciences. 2017;07(04). doi:10.4172/2155-9600.1000615
  10. Roughead ZK, Zito CA, Hunt JR. Inhibitory effects of dietary calcium on the initial uptake and subsequent retention of heme and nonheme iron in humans: comparisons using an intestinal lavage method. Am J Clin Nutr. 2005;82(3):589–597. doi:10.1093/ajcn.82.3.589.
  11. Brown Jr EB, Dubach R, Moore CV. Studies in iron transportation and metabolism. 11. Critical analysis of mucosal block by large doses of inorganic iron in human subjects. J Lab Clin Med. 1958;52:335–355.
  12. Halliwell B. Antioxidants in Human Health and Disease. Annual Review of Nutrition. 1996;16(1):33-50. doi:10.1146/annurev.nu.16.070196.000341
  13. Halliwell B. The antioxidant paradox. The Lancet. 2000;355(9210):1179-1180. doi:10.1016/s0140-6736(00)02075-4
  14. Wang L, Li Q, Duan XL, Chang YZ. Effects of extracellular iron concentration on calcium absorption and relationship between Ca2+ and cell apoptosis in Caco-2 cells. World J Gastroenterol. 2005;11(19):2916–2921. doi:3748/wjg.v11.i19.291.
  15. Meydani M. Antioxidants in the prevention of chronic diseases. Nutrition in clinical care: an official publication of Tufts University. 2002;5(2):47–49. doi:1046/j.1523-5408.2002.00002.x.
  16. Rutkowski M, Grzegorczyk K. Adverse effects of antioxidative vitamins. International Journal of Occupational Medicine and Environmental Health. 2012;25(2). doi:10.2478/s13382-012-0022-x
  17. Schiavone G, Raskovic D, Greco J, Abeni D. Platelet-Rich Plasma for Androgenetic Alopecia. Dermatologic Surgery. 2014;40(9):1010-1019. doi:10.1097/01.dss.0000452629.76339.2b
  18. Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR, et al. Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind Study. American Journal of Clinical Dermatology. 2014;15(2):115-127. doi:10.1007/s40257-013-0060-6
  19. Kim H, Choi JW, Kim JY, Shin JW, Lee SJ, Huh CH. Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Sham Device–Controlled Multicenter Trial. Dermatologic Surgery. 2013;39(8):1177-1183. doi:10.1111/dsu.12200
Support